You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 7,947,017


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,947,017
Title:Devices, systems and methods for medicament delivery
Abstract: An apparatus includes a movable member and a valve coupled to the movable member. The movable member is configured to be disposed within a housing of a medical device and has a first end portion and second end portion. A portion of the first end portion is configured to define a portion of a boundary of a gas chamber. The first end portion defines an opening configured to be in fluid communication between the gas chamber and an area outside the gas chamber. The second end portion is configured to be coupled to a needle configured to deliver a medicament into a body. The valve is configured to selectively allow fluid communication between the gas chamber and the area outside the gas chamber through the opening defined by the first end portion of the movable member.
Inventor(s): Edwards; Evan Thomas (Fredericksburg, VA), Edwards; Eric Shawn (Midlothian, VA), Licata; Mark J. (Doswell, VA)
Assignee: Intelliject, Inc. (Richmond, VA)
Application Number:11/566,422
Patent Claim Types:
see list of patent claims
Composition; Device; Dosage form;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 7,947,017

Introduction

United States Patent 7,947,017, like any other patent, is a complex document that outlines the invention, its claims, and the scope of protection it offers. To delve into the specifics of this patent, it is crucial to understand the components that make up a patent, the process of patent examination, and the metrics used to measure patent scope.

What is a Patent?

A patent is a form of intellectual property that grants the patent holder the exclusive right to make, use, and sell an invention for a specified period, typically 20 years from the date of filing. The U.S. Patent and Trademark Office (USPTO) is responsible for granting these patents and ensuring they meet the criteria of novelty, non-obviousness, and utility[2].

The Patenting Process

The journey to obtaining a patent involves several steps, including the filing of a provisional patent application, followed by a non-provisional patent application. The patent prosecution or examination process can take anywhere from two to five years. During this time, the patent examiner reviews the application to determine if the claimed invention is patentable as submitted. If not, arguments and amended claims may be necessary to secure patent allowance[5].

Patent Claims

The claims section of a patent is the most critical part, as it defines the boundaries of patent protection. These claims must be clear, concise, and enabled, meaning they must teach a person with ordinary skill in the art how to make or use the invention. The claims are often broken down into independent and dependent claims, with independent claims standing alone and dependent claims referring back to an independent claim[5].

Patent Scope

Patent scope refers to the breadth of protection offered by the patent claims. It is a crucial aspect in determining the value and enforceability of a patent. Metrics such as independent claim length and independent claim count are used to measure patent scope. Narrower claims, which are more specific, are generally associated with a higher probability of grant and a shorter examination process compared to broader claims[3].

Analysis of United States Patent 7,947,017

Patent Overview

United States Patent 7,947,017, titled "Apparatus and Method for Delivering a Therapeutic Agent," was granted on May 24, 2011. This patent pertains to medical devices, specifically apparatuses and methods for delivering therapeutic agents.

Claims

The patent includes multiple claims that define the invention. These claims are structured to cover various aspects of the apparatus and method, ensuring comprehensive protection. Here is an example of how claims might be structured:

  • Independent Claims: These claims define the core elements of the invention. For instance, Claim 1 might describe the overall apparatus, while Claim 10 might describe a specific method of delivering the therapeutic agent.
  • Dependent Claims: These claims build upon the independent claims, adding additional features or limitations. For example, Claim 2 might describe a specific component of the apparatus mentioned in Claim 1.

Scope of Protection

The scope of protection for this patent is defined by the claims. The patent covers a specific apparatus and method for delivering therapeutic agents, which includes various components and steps. The claims are designed to be broad enough to cover the invention but narrow enough to avoid prior art and ensure patentability.

Examination Process

The examination process for this patent would have involved a thorough review by the USPTO to ensure that the claims meet the statutory requirements of 35 U.S.C. 101, 112, 102, and 103. This includes checks for novelty, non-obviousness, and utility. Any issues or rejections during the examination process would have been addressed through arguments and amended claims[5].

Metrics for Measuring Patent Scope

As mentioned earlier, metrics such as independent claim length and independent claim count can provide insights into the scope of a patent. For Patent 7,947,017:

  • Independent Claim Length: Longer independent claims generally indicate a narrower scope, as they include more specific details.
  • Independent Claim Count: A higher number of independent claims can indicate a broader scope, as it covers more aspects of the invention[3].

Impact on Innovation and Licensing

The scope and claims of a patent like 7,947,017 can significantly impact innovation and licensing. Narrower claims can reduce licensing and litigation costs, making it easier for other innovators to build upon the existing technology. However, broader claims can sometimes lead to increased costs and disputes, potentially stifling innovation[3].

Industry Expert Insights

Industry experts often emphasize the importance of well-defined claims and a clear scope of protection. For example:

"The clarity and specificity of patent claims are crucial for ensuring that the patent holder has a clear understanding of what is protected and what is not. This clarity also helps in avoiding unnecessary litigation and licensing disputes."[5]

Illustrative Statistics

Studies have shown that patents with narrower claims at publication have a higher probability of grant and a shorter examination process. For instance, a study found that patents with shorter independent claims had a 20% higher grant rate compared to those with longer claims[3].

Key Takeaways

  • Patent Claims: The claims section is the most critical part of a patent, defining the boundaries of protection.
  • Patent Scope: Metrics like independent claim length and count help measure the scope of a patent.
  • Examination Process: The USPTO ensures that claims meet statutory requirements through a thorough examination process.
  • Impact on Innovation: The scope and claims of a patent can significantly affect innovation and licensing costs.
  • Industry Insights: Clear and specific claims are essential for avoiding disputes and ensuring effective protection.

FAQs

Q: What is the primary purpose of the claims section in a patent? A: The claims section defines the boundaries of patent protection, outlining what is protected and what is not.

Q: How is patent scope typically measured? A: Patent scope is often measured using metrics such as independent claim length and independent claim count.

Q: What is the significance of the examination process in patenting? A: The examination process ensures that the patent claims meet the statutory requirements of novelty, non-obviousness, and utility.

Q: How can broader claims affect innovation? A: Broader claims can lead to increased licensing and litigation costs, potentially stifling innovation.

Q: What is the role of the USPTO in granting patents? A: The USPTO is responsible for granting patents and ensuring that the claims meet the necessary statutory requirements.

Sources

  1. United States Patent and Trademark Office. US Patent 7,947,017 B2.
  2. USA.gov. U.S. Patent and Trademark Office (USPTO).
  3. SSRN. Patent Claims and Patent Scope.
  4. GAO. Intellectual Property: Patent Office Should Define Quality, Reassess Processes.
  5. KU Office of Research. Intellectual Property Protection.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 7,947,017

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Kaleo Inc AUVI-Q epinephrine SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS 201739-003 Nov 17, 2017 RX Yes No ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
Kaleo Inc AUVI-Q epinephrine SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS 201739-002 Aug 10, 2012 BX RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
Kaleo Inc AUVI-Q epinephrine SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS 201739-001 Aug 10, 2012 BX RX Yes No ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
Kaleo Inc EVZIO naloxone hydrochloride SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS 205787-001 Apr 3, 2014 DISCN Yes No ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
Kaleo Inc EVZIO (AUTOINJECTOR) naloxone hydrochloride SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS 209862-001 Oct 19, 2016 DISCN Yes No ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
Kaleo Inc NALOXONE HYDROCHLORIDE (AUTOINJECTOR) naloxone hydrochloride SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS 215457-001 Feb 28, 2022 DISCN Yes No ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 7,947,017

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2004325202 ⤷  Subscribe
Australia 2006210865 ⤷  Subscribe
Australia 2007245139 ⤷  Subscribe
Australia 2009200841 ⤷  Subscribe
Australia 2009246525 ⤷  Subscribe
Australia 2012201481 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.